Bnp Paribas Asset Management Holding S.A. Edgewise Therapeutics, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $38.6 Billion
- Q3 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 521 shares of EWTX stock, worth $11,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
521
Previous 454
14.76%
Holding current value
$11,852
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
186Shares Held
112MCall Options Held
188KPut Options Held
121K-
Orbimed Advisors LLC San Diego, CA15.5MShares$353 Million8.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.4MShares$237 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY7.31MShares$166 Million0.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.17MShares$140 Million3.22% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$137 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.44B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...